ArticleThe Journal of experimental medicine2023

Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy.

Romina Marone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.